Showing 2451-2460 of 4063 results for "".
- Visible Genomics Wins 2025 AMD Genetic Testing Company of the Year Awardhttps://modernod.com/news/visible-genomics-wins-2025-amd-genetic-testing-company-of-the-year-award/2482619/Visible Genomics, a provider of genetic testing solutions for severe ocular diseases, was named 'Life Sciences Review AMD Genetic Testing Company of the Year 2025.' This award recognizes the company’s innovative contributions to proactive care for advanced age-related macular degene
- Sling Therapeutics Announces Positive Topline Results from Phase 2b/3 LIDS Trial of Linsitinib in Patients with TEDhttps://modernod.com/news/sling-therapeutics-announces-positive-topline-results-from-phase-2b3-lids-trial-of-oral-small-molecule-linsitinib-in-patients-with-ted/2482614/Sling Therapeutics announced topline efficacy and safety data from the phase 2b/3 LIDS trial of linsitinib in patients with active, moderate to severe Thyroid Eye Disease (TED). Linsitinib, Sling’s lead product candidate, is an oral small molecule, taken twice-daily
- Aviceda Therapeutics Raises $207.5 Million to Advance Lead Program AVD-104 for Geographic Atrophy into Phase 3 Testinghttps://modernod.com/news/aviceda-therapeutics-raises-2075-million-to-advance-lead-program-avd-104-for-geographic-atrophy-into-phase-3-testing/2482603/Aviceda Therapeutics announced the closing of a $207.5 million Series C financing to propel the company’s pivotal phase 3 clinical trial for AVD-104, a treatment candidate for geographic atrophy
- OneSight EssilorLuxottica Foundation Partners with WHO on SPECS 2030 Initiativehttps://modernod.com/news/onesight-essilorluxottica-foundation-partners-with-who-on-specs-2030-initiative-1/2482570/The OneSight EssilorLuxottica Foundation has announced a collaboration with the World Health Organization (WHO) as a global partner in the SPECS 2030 initiative. This strategic alliance is set to accelerate progress toward the world’s first global target for effective refractive error cover
- MediPrint Ophthalmics Unveils Phase 2b Trial Results for Drug-Eluting Contact Lens in Glaucoma Treatmenthttps://modernod.com/news/mediprint-ophthalmics-unveils-phase-2b-trial-results-for-drug-eluting-contact-lens-in-glaucoma-treatment/2482539/MediPrint Ophthalmics announced positive results from its phase 2b clinical trial of its 3D-printed, drug-eluting contact lens LL-BMT1. The results, presented by Ian Ben Gaddie, OD, FAAO, at the Ameri
- Johnson & Johnson to Showcase Tecnis Odyssey IOL and Present New Research at AAO 2024https://modernod.com/news/johnson-johnson-to-showcase-tecnis-odyssey-iol-and-present-new-research-at-aao-2024/2482501/Johnson & Johnson will highlight its latest innovations in eye health during the 2024 American Academy of Ophthalmology (AAO) annual meeting, taking place from October 18-21 in Chicago. Among the company's spotlight advancements is the Tecnis Odyssey IOL, a new presbyopia-correcting IOL t
- Bausch + Lomb Announces New Data and Events at the 2024 AAO Annual Meeting in Chicagohttps://modernod.com/news/bausch-lomb-announces-new-data-and-events-at-the-2024-aao-annual-meeting-in-chicago/2482493/Bausch + Lomb announced its upcoming presentations and educational events at the American Academy of Ophthalmology (AAO) annual meeting, taking place in Chicago from October 18-21, 2024. The company will showcase new scientific data on its eye health products and technologies, incl
- Haag-Streit to Host "Biometry Focus Month 2024" with Weekly Webinars in Novemberhttps://modernod.com/news/haag-streit-to-host-biometry-focus-month-2024-with-weekly-webinars-in-november/2482492/Haag-Streit has announced the return of "Biometry Focus Month 2024" in November. The event will feature a series of live webinars every Thursday from November 7 to November 28, 2024. Each session will address critical topics in biometry, offering cataract and refractive surgeons ke
- Alcon to Showcase Latest Innovations at AAO 2024 Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-at-aao-2024-annual-meeting/2482489/Alcon will unveil its latest clinical data and product innovations at the American Academy of Ophthalmology (AAO) 2024 annual meeting. Attendees, including ophthalmologists, surgical staff, researchers, and industry leaders, are invited to visit Alcon at booth #4008 for hands-on demonstrations an
- Centricity Vision Unveils Enhancements to ZEPTOLink IOL Positioning System at AAO 2024https://modernod.com/news/centricity-vision-unveils-enhancements-to-zeptolink-iol-positioning-system-at-aao-2024/2482487/Centricity Vision announced platform enhancements for its ZEPTOLink IOL Positioning System designed to reduce treatment time by up to 60%. The enhancements will be highlighted at the American Academy of Ophthalmology (AAO) annual meeting, taking place from October 18-21, 2024, in Chicago.